HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,810,136 | +30.2% | 361,398 | +15.7% | 0.01% | +37.5% |
Q2 2023 | $32,122,009 | -27.7% | 312,319 | -23.2% | 0.01% | -33.3% |
Q1 2023 | $44,401,863 | -30.9% | 406,834 | -28.0% | 0.01% | -36.8% |
Q4 2022 | $64,260,356 | -62.7% | 564,678 | -79.7% | 0.02% | -65.5% |
Q3 2022 | $172,154,000 | +37.2% | 2,781,599 | +76.9% | 0.06% | +44.7% |
Q2 2022 | $125,442,000 | +32.5% | 1,572,734 | +74.7% | 0.04% | +58.3% |
Q1 2022 | $94,692,000 | -17.6% | 900,030 | -15.6% | 0.02% | -14.3% |
Q4 2021 | $114,977,000 | -19.7% | 1,066,965 | -18.4% | 0.03% | -22.2% |
Q3 2021 | $143,252,000 | +9.4% | 1,307,752 | -6.5% | 0.04% | +12.5% |
Q2 2021 | $130,916,000 | +0.9% | 1,398,085 | -0.8% | 0.03% | -8.6% |
Q1 2021 | $129,688,000 | +147.5% | 1,409,050 | +96.7% | 0.04% | +133.3% |
Q4 2020 | $52,403,000 | -72.5% | 716,380 | -70.8% | 0.02% | -76.6% |
Q3 2020 | $190,472,000 | +23.4% | 2,452,023 | -11.7% | 0.06% | +16.4% |
Q2 2020 | $154,396,000 | +78.6% | 2,777,935 | -4.8% | 0.06% | +52.8% |
Q1 2020 | $86,433,000 | -31.6% | 2,918,086 | -16.4% | 0.04% | -7.7% |
Q4 2019 | $126,327,000 | +44.9% | 3,489,708 | +9.0% | 0.04% | +69.6% |
Q3 2019 | $87,163,000 | +451.7% | 3,200,990 | +387.4% | 0.02% | +475.0% |
Q2 2019 | $15,800,000 | – | 656,693 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |